New pill trial aims to tame severe eczema itch and rash
NCT ID NCT07441395
Summary
This study is testing whether a new oral medication called soquelitinib can safely reduce the rash and itch of moderate to severe eczema (atopic dermatitis). About 200 adults will take either the real pill or a placebo (a dummy pill with no medicine) daily for 12 weeks. Doctors will closely monitor changes in skin condition, itch levels, and any side effects to see if the treatment is effective and well-tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corvus Clinical Trials
RECRUITINGSouth San Francisco, California, 94080, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.